{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:39:03Z","timestamp":1792273143743,"version":"4.4.0"},"reference-count":231,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["SF2022-2-2035"],"award-info":[{"award-number":["SF2022-2-2035"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070948,82101138"],"award-info":[{"award-number":["82070948,82101138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.addr.2023.114899","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:18:26Z","timestamp":1684927106000},"page":"114899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Advances in development of exosomes for ophthalmic therapeutics"],"prefix":"10.1016","volume":"199","author":[{"given":"Ying","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0005","doi-asserted-by":"crossref","first-page":"e1460","DOI":"10.1016\/S2214-109X(21)00212-6","article-title":"Keeping an eye on eye care: monitoring progress towards effective coverage","volume":"9","author":"Keel","year":"2021","journal-title":"Lancet Glob. Health"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjophthalmol-2011-300581","article-title":"Surgical outcome and risk stratification for primary retinal detachment repair: results from the Scottish Retinal Detachment study","volume":"96","author":"Mitry","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0015","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.survophthal.2020.09.005","article-title":"Microinvasive glaucoma surgery: a review of 3476 eyes","volume":"66","author":"Nichani","year":"2021","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ICU.0000000000000547","article-title":"Cataract surgery and lens implantation","volume":"30","author":"Li","year":"2019","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0025","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/IAE.0000000000001793","article-title":"Visual and anatomical outcomes after diabetic traction and traction-rhegmatogenous retinal detachment repair","volume":"38","author":"Storey","year":"2018","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"7","key":"10.1016\/j.addr.2023.114899_b0030","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.ophtha.2016.02.040","article-title":"Pharmacotherapies for retinal detachment","volume":"123","author":"Wubben","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2023.114899_b0035","unstructured":"U.V. Shukla, K. Tripathy, Diabetic retinopathy, in: StatPearls. edn. Treasure Island (FL), 2022."},{"key":"10.1016\/j.addr.2023.114899_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102500","article-title":"Alterations in corneal biomechanics underlie early stages of autoimmune-mediated dry eye disease","volume":"114","author":"Efraim","year":"2020","journal-title":"J. Autoimmun."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114899_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109162","article-title":"Quantitative pharmacokinetic analyses of anterior and posterior elimination routes of intravitreal anti-VEGF macromolecules using published human and rabbit data","volume":"222","author":"Lamminsalo","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.addr.2023.114899_b0055","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221133818","article-title":"Mesenchymal stromal cell-based therapy for dry eye: current status and future perspectives","volume":"31","author":"Jiang","year":"2022","journal-title":"Cell Transplant."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b0060","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00417-018-4097-3","article-title":"Effects of mesenchymal stem cells and their exosomes on the healing of large and refractory macular holes","volume":"256","author":"Zhang","year":"2018","journal-title":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"10.1016\/j.addr.2023.114899_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100779","article-title":"Retinal stem cell transplantation: Balancing safety and potential","volume":"75","author":"Singh","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.addr.2023.114899_b0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preteyeres.2016.10.002","article-title":"Advances in bone marrow stem cell therapy for retinal dysfunction","volume":"56","author":"Park","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5966\/sctm.2016-0038","article-title":"Exosomes derived from Akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D","volume":"6","author":"Ma","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0080","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.116.024590","article-title":"Exosomal MicroRNA transfer into macrophages mediates cellular postconditioning","volume":"136","author":"de Couto","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","article-title":"Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology","volume":"116","author":"Gray","year":"2015","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.healun.2016.01.013","article-title":"Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure","volume":"35","author":"Kervadec","year":"2016","journal-title":"J. Heart Lung Transplant."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b0095","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/cvr\/cvx118","article-title":"Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis","volume":"113","author":"Ribeiro-Rodrigues","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061122","article-title":"Engineering exosomes for cancer therapy","volume":"18","author":"Gilligan","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.114899_b0105","article-title":"Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy","volume":"8(2):eabj8207","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2023.114899_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.650426","article-title":"Exosome-based delivery of natural products in cancer therapy","volume":"9","author":"Song","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.addr.2023.114899_b0115","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.7150\/thno.64229","article-title":"Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment","volume":"11","author":"Bu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2023.114899_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101771","article-title":"Salwa, Duo Y, Tang BZ: Exosome nanovesicles: A potential carrier for therapeutic delivery","volume":"49","author":"Chavda","year":"2023","journal-title":"Nano Today"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/aos.14932","article-title":"Advances in exosome therapies in ophthalmology-From bench to clinical trial","volume":"100","author":"Sanghani","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.addr.2023.114899_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121949","article-title":"Exosomes based strategies for brain drug delivery","volume":"293","author":"Rehman","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114899_b0135","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.2147\/IJN.S264498","article-title":"Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114899_b0140","doi-asserted-by":"crossref","unstructured":"L. Fan, C. Liu, X. Chen, L. Zheng, Y. Zou, H. Wen, P. Guan, F. Lu, Y. Luo, G. Tan, et al: Exosomes-loaded electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via immunoregulation and enhancement of myelinated axon growth, Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany) 2022, 9(13):e2105586.","DOI":"10.1002\/advs.202105586"},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040307","article-title":"Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes","volume":"8","author":"Gurunathan","year":"2019","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.addr.2023.114899_b0150","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","article-title":"Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)","volume":"262","author":"Johnstone","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0155","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/ijms16011509","article-title":"Membrane trafficking in the yeast Saccharomyces cerevisiae model","volume":"16","author":"Feyder","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.addr.2023.114899_b0160","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.4161\/cc.8.13.8988","article-title":"Microvesicles: messengers and mediators of tumor progression","volume":"8","author":"Al-Nedawi","year":"2009","journal-title":"Cell Cycle"},{"issue":"7559","key":"10.1016\/j.addr.2023.114899_b0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.addr.2023.114899_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.addr.2023.114899_b0185","article-title":"A comparative proteomics analysis identified differentially expressed proteins in pancreatic cancer-associated stellate cell small extracellular vesicles","volume":"100438","author":"Sarcar","year":"2022","journal-title":"Mol. Cell Proteom."},{"issue":"6478","key":"10.1016\/j.addr.2023.114899_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.addr.2023.114899_b0195","doi-asserted-by":"crossref","first-page":"20121","DOI":"10.1074\/jbc.273.32.20121","article-title":"Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes","volume":"273","author":"Escola","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.114899_b0200","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.immunol.20.100301.064801","article-title":"Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses","volume":"20","author":"Srivastava","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0205","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1038\/s41467-021-24384-2","article-title":"Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9","volume":"12","author":"Mathieu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2023.114899_b0210","doi-asserted-by":"crossref","unstructured":"Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH, Chen C, Li H, Li P, Quinn D, Dao M et al: Isolation of exosomes from whole blood by integrating acoustics and microfluidics, Proc. Natl. Acad. Sci. USA 2017, 114(40):10584-10589.","DOI":"10.1073\/pnas.1709210114"},{"key":"10.1016\/j.addr.2023.114899_b0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2019.02.021","article-title":"Advances in exosomes technology","volume":"493","author":"Chen","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0220","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0225","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/10408363.2016.1190682","article-title":"Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction","volume":"53","author":"Foster","year":"2016","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.addr.2023.114899_b0230","doi-asserted-by":"crossref","unstructured":"S. Tiwari, V. Kumar, S. Randhawa, S. Verma, Preparation and characterization of extracellular vesicles, Am. J. Reprod. Immunol. (New York, NY : 1989) 2021, 85(2):e13367.","DOI":"10.1111\/aji.13367"},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2023.114899_b0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","article-title":"Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy","volume":"150","author":"Tian","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","article-title":"Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations","volume":"14","author":"Kim","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0250","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13287-022-02780-9","article-title":"Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0255","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/0008-5472.CAN-17-2880","article-title":"Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery","volume":"78","author":"Wan","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2023.114899_b0260","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114899_b0265","doi-asserted-by":"crossref","first-page":"21933","DOI":"10.1038\/srep21933","article-title":"Engineering hybrid exosomes by membrane fusion with liposomes","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0270","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050998","article-title":"Ocular Barriers and Their Influence on Gene Therapy Products Delivery","volume":"14","author":"Leclercq","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.addr.2023.114899_b0280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/1061186X.2021.1878366","article-title":"A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances","volume":"29","author":"Wang","year":"2021","journal-title":"J. Drug Target."},{"issue":"7","key":"10.1016\/j.addr.2023.114899_b0285","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/stem.1771","article-title":"HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing","volume":"33","author":"Zhang","year":"2015","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"10.1016\/j.addr.2023.114899_b0290","doi-asserted-by":"crossref","unstructured":"Wang J, Huizinga TW, Toes RE: De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. Journal of immunology (Baltimore, Md : 1950) 2009, 183(6):4119-4126.","DOI":"10.4049\/jimmunol.0901065"},{"issue":"37","key":"10.1016\/j.addr.2023.114899_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909125","article-title":"Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration","volume":"30","author":"Brennan","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b0300","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41551-021-00764-3","article-title":"Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells","volume":"5","author":"Tian","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.addr.2023.114899_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116733","article-title":"Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment","volume":"233","author":"Yaghoubi","year":"2019","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0310","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1073\/pnas.1310501111","article-title":"Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion","volume":"111","author":"Atay","year":"2014","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.addr.2023.114899_b0315","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.addr.2023.114899_b0320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","article-title":"Progress in corneal wound healing","volume":"49","author":"Ljubimov","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0325","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1080\/07853890.2022.2045035","article-title":"Neurotrophic keratopathy: current challenges and future prospects","volume":"54","author":"NaPier","year":"2022","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0330","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","article-title":"Update on ocular graft-versus-host disease","volume":"69","author":"Nair","year":"2021","journal-title":"Indian J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091483","article-title":"Goals and Challenges of Stem Cell-Based Therapy for Corneal Blindness Due to Limbal Deficiency","volume":"13","author":"Calonge","year":"2021","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.addr.2023.114899_b0340","volume":"21","author":"Theerakittayakorn","year":"2020","journal-title":"Differentiation Induction of Human Stem Cells for Corneal Epithelial Regeneration. International journal of molecular sciences"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0345","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s12015-013-9449-0","article-title":"Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction","volume":"9","author":"Holan","year":"2013","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0350","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jbm.b.34455","article-title":"Bioengineered corneal epithelial cell sheet from mesenchymal stem cells-A functional alternative to limbal stem cells for ocular surface reconstruction","volume":"108","author":"Venugopal","year":"2020","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b0355","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5966\/sctm.2015-0039","article-title":"A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction","volume":"4","author":"Holan","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"12","key":"10.1016\/j.addr.2023.114899_b0360","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.18-24803","article-title":"Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing","volume":"59","author":"Samaeekia","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.114899_b0365","doi-asserted-by":"crossref","first-page":"40548","DOI":"10.1038\/srep40548","article-title":"Potential role of corneal epithelial cell-derived exosomes in corneal wound healing and neovascularization","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.addr.2023.114899_b0370","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.18632\/aging.103904","article-title":"Comparison of exosomes derived from induced pluripotent stem cells and mesenchymal stem cells as therapeutic nanoparticles for treatment of corneal epithelial defects","volume":"12","author":"Wang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.addr.2023.114899_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121320","article-title":"Exosomes-loaded thermosensitive hydrogels for corneal epithelium and stroma regeneration","volume":"280","author":"Tang","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0380","doi-asserted-by":"crossref","first-page":"e21200","DOI":"10.1096\/fj.202001106RRR","article-title":"Thrombospondin 1-induced exosomal proteins attenuate hypoxia-induced paraptosis in corneal epithelial cells and promote wound healing","volume":"35","author":"Lai","year":"2021","journal-title":"Faseb j"},{"key":"10.1016\/j.addr.2023.114899_b0385","first-page":"415","article-title":"Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity","volume":"25","author":"Call","year":"2019","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0390","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4103\/0366-6999.226889","article-title":"Effects of Adipose-derived Mesenchymal Stem Cell Exosomes on Corneal Stromal Fibroblast Viability and Extracellular Matrix Synthesis","volume":"131","author":"Shen","year":"2018","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0395","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.18632\/aging.102802","article-title":"Exosomal miR-19a from adipose-derived stem cells suppresses differentiation of corneal keratocytes into myofibroblasts","volume":"12","author":"Shen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.addr.2023.114899_b0400","doi-asserted-by":"crossref","unstructured":"Shojaati G, Khandaker I, Funderburgh M, Mann M, Basu R, Stolz D, Geary M, Dos Santos A, Deng S, Funderburgh J: Mesenchymal Stem Cells Reduce Corneal Fibrosis and Inflammation via Extracellular Vesicle-Mediated Delivery of miRNA. Stem cells translational medicine 2019, 8(11):1192-1201.","DOI":"10.1002\/sctm.18-0297"},{"issue":"8","key":"10.1016\/j.addr.2023.114899_b0405","volume":"23","author":"Escandon","year":"2022","journal-title":"Unravelling Novel Roles of Salivary Exosomes in the Regulation of Human Corneal Stromal Cell Migration and Wound Healing. International journal of molecular sciences"},{"issue":"12","key":"10.1016\/j.addr.2023.114899_b0410","first-page":"2196","article-title":"The prevalence and 5-year incidence of ocular trauma","volume":"107","author":"Wong","year":"2000","journal-title":"The Beaver Dam Eye Study. Ophthalmology"},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0415","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1167\/iovs.11-8564","article-title":"Animal models of retinal injury","volume":"53","author":"Blanch","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0420","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/eye.2010.190","article-title":"Ophthalmic injuries in British Armed Forces in Iraq and Afghanistan","volume":"25","author":"Blanch","year":"2011","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.addr.2023.114899_b0425","doi-asserted-by":"crossref","unstructured":"Viestenz A, K\u00fcchle M: [Blunt ocular trauma. Part II. Blunt posterior segment trauma]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2005, 102(1):89-99; quiz 100-101.","DOI":"10.1007\/s00347-004-1137-7"},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b0430","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/sctm.16-0428","article-title":"Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms","volume":"6","author":"Mead","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.addr.2023.114899_b0435","article-title":"Exosome-Mediated Delivery of the Neuroprotective Peptide PACAP38 Promotes Retinal Ganglion Cell Survival and Axon Regeneration in Rats With Traumatic Optic Neuropathy","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2023.114899_b0440","doi-asserted-by":"crossref","first-page":"34562","DOI":"10.1038\/srep34562","article-title":"Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0445","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jtos.2019.01.001","article-title":"Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD","volume":"17","author":"Mart\u00ednez-Carrasco","year":"2019","journal-title":"Ocul. Surf."},{"issue":"7","key":"10.1016\/j.addr.2023.114899_b0450","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/bloodadvances.2018028431","article-title":"Ocular instillation of vitamin A-coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD","volume":"3","author":"Ohigashi","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0455","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren\u2019s Syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.addr.2023.114899_b0460","volume":"22","author":"Ogawa","year":"2021","journal-title":"Autoimmune Epithelitis and Chronic Inflammation in Sj\u00f6gren's Syndrome-Related Dry Eye Disease. International journal of molecular sciences"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0465","first-page":"339","article-title":"The conjunctiva in acute and chronic mucous membrane pemphigoid","volume":"100","author":"Bernauer","year":"1993","journal-title":"An immunohistochemical analysis. Ophthalmology"},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0470","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/09273948.2021.1939390","article-title":"A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management","volume":"29","author":"Carreno-Galeano","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b0475","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0161-6420(88)33165-9","article-title":"Episodic conjunctival inflammation after Stevens-Johnson syndrome","volume":"95","author":"Foster","year":"1988","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0480","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/jop.2019.0060","article-title":"The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options","volume":"36","author":"Periman","year":"2020","journal-title":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0485","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/OPX.0000000000001071","article-title":"A Review of Ocular Graft-Versus-Host Disease","volume":"94","author":"Munir","year":"2017","journal-title":"Optometry and vision science : official publication of the American Academy of Optometry"},{"key":"10.1016\/j.addr.2023.114899_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2021.101224","article-title":"Corneal perforation in ocular graft-versus-host disease","volume":"24","author":"Zhang","year":"2021","journal-title":"American journal of ophthalmology case reports"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0495","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/bmt.2016.221","article-title":"Long-term safety and efficacy of autologous platelet lysate drops for treatment of ocular GvHD","volume":"52","author":"Pezzotta","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.addr.2023.114899_b0500","article-title":"Exosomes derived from mouse adipose-derived mesenchymal stem cells alleviate BAC-induced Mouse Dry Eye Model Via Inhibiting NLRP3 Inflammasome","author":"Wang","year":"2021","journal-title":"Ophthal. Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0505","doi-asserted-by":"crossref","first-page":"14521","DOI":"10.1038\/s41598-020-71337-8","article-title":"hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye","volume":"10","author":"Yu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114899_b0510","article-title":"Yi W et al.: miR-204-containing exosomes ameliorate GVHD-associated dry eye disease","volume":"8(2):eabj9617","author":"Zhou","year":"2022","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0515","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09286586.2021.1882506","article-title":"Garc\u00eda de Y\u00e9benes MJ, Ot\u00f3n T, Mu\u00f1oz-Fern\u00e1ndez S: Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis","volume":"28","author":"Garc\u00eda-Aparicio","year":"2021","journal-title":"Ophthalmic Epidemiol."},{"issue":"4\u20135","key":"10.1016\/j.addr.2023.114899_b0520","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.autrev.2014.01.006","article-title":"Diagnosis and classification of autoimmune uveitis","volume":"13","author":"Selmi","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.addr.2023.114899_b0525","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Beh\u00e7et's disease","volume":"70","author":"Benezra","year":"1986","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.114899_b0530","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000336338","article-title":"New treatment options for noninfectious uveitis","volume":"51","author":"Gomes Bittencourt","year":"2012","journal-title":"Dev. Ophthalmol."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0535","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10238-015-0345-6","article-title":"Autoimmune uveitis: clinical, pathogenetic, and therapeutic features","volume":"16","author":"Prete","year":"2016","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000317909","article-title":"Intravitreal triamcinolone","volume":"225","author":"Tao","year":"2011","journal-title":"Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde"},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0545","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4155\/tde-2019-0024","article-title":"Dexamethasone intravitreal implant (OZURDEX(\u00ae)) for macular edema secondary to noninfectious uveitis: a review of the literature","volume":"10","author":"Massa","year":"2019","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2023.114899_b0550","doi-asserted-by":"crossref","unstructured":"L.R. Steeples, S. Pockar, N.P. Jones, Leal I: evaluating the safety, efficacy and patient acceptability of intravitreal fluocinolone acetonide (0.2mcg\/day) implant in the treatment of non-infectious uveitis affecting the posterior segment, Clin. Ophthalmol. (Auckland, NZ) 2021, 15:1433-1442.","DOI":"10.2147\/OPTH.S216912"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0555","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/14728214.2019.1663823","article-title":"Emerging drugs for the treatment of noninfectious uveitis","volume":"24","author":"Pleyer","year":"2019","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0560","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0565","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0570","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/1744666X.2017.1288097","article-title":"Adalimumab for the treatment of uveitis","volume":"13","author":"LaMattina","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0575","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/25785826.2019.1642080","article-title":"The effectiveness of adalimumab treatment for non-infectious uveitis","volume":"42","author":"Hasegawa","year":"2019","journal-title":"Immunological medicine"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0580","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/09273948.2015.1134581","article-title":"Adalimumab for Ocular Inflammation","volume":"25","author":"Durrani","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0585","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1167\/iovs.15-18353","article-title":"Modulation of immune responses by extracellular vesicles from retinal pigment epithelium","volume":"57","author":"Knickelbein","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0590","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1038\/s41598-017-04559-y","article-title":"Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis","volume":"7","author":"Bai","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0595","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","article-title":"MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis","volume":"8","author":"Shigemoto-Kuroda","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2023.114899_b0600","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3389\/fimmu.2020.01051","article-title":"Interleukin 35-producing exosomes suppress neuroinflammation and autoimmune uveitis","volume":"11","author":"Kang","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b0605","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"9735","key":"10.1016\/j.addr.2023.114899_b0610","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b0615","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41433-020-1010-1","article-title":"An evidence map of clinical practice guideline recommendations and quality on diabetic retinopathy","volume":"34","author":"Sun","year":"2020","journal-title":"Eye (Lond.)"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0620","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","article-title":"Panretinal photocoagulation: a review of complications","volume":"33","author":"Reddy","year":"2018","journal-title":"Semin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0625","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial","volume":"123","author":"Wells","year":"2016","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0630","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"issue":"1\u20132","key":"10.1016\/j.addr.2023.114899_b0635","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1900\/RDS.2015.12.159","article-title":"Biomarkers in diabetic retinopathy","volume":"12","author":"Jenkins","year":"2015","journal-title":"Rev. Diabetic Stud.: RDS"},{"key":"10.1016\/j.addr.2023.114899_b0640","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0645","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.survophthal.2021.03.001","article-title":"Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: a review","volume":"66","author":"Tan","year":"2021","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0650","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11739-019-02253-7","article-title":"Intravitreal anti-VEGF agents and cardiovascular risk","volume":"15","author":"Porta","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.addr.2023.114899_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119232","article-title":"MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p\/XBP1 axis","volume":"272","author":"Cao","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0660","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1167\/iovs.18-25617","article-title":"Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1","volume":"60","author":"Zhang","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.114899_b0665","doi-asserted-by":"crossref","DOI":"10.1177\/1849454418807827","article-title":"Adipose mesenchymal stem cells-derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits","volume":"7","author":"Safwat","year":"2018","journal-title":"J. Circulat. Biomark."},{"issue":"7","key":"10.1016\/j.addr.2023.114899_b0670","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1002\/jcp.30213","article-title":"Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1","volume":"236","author":"Gu","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2023.114899_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108271","article-title":"Retinal pigment epithelial cells secrete miR-202-5p-containing exosomes to protect against proliferative diabetic retinopathy","volume":"201","author":"Gu","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0680","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum. Dev."},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b0685","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/archdischild-2016-310532","article-title":"Epidemiology of blindness in children","volume":"102","author":"Solebo","year":"2017","journal-title":"Arch Dis Child"},{"issue":"26","key":"10.1016\/j.addr.2023.114899_b0690","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.addr.2023.114899_b0695","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/ATVBAHA.113.301331","article-title":"Microglia and interleukin-1\u03b2 in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A","volume":"33","author":"Rivera","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0700","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.survophthal.2016.12.004","article-title":"Advances in understanding and management of retinopathy of prematurity","volume":"62","author":"Hartnett","year":"2017","journal-title":"Surv. Ophthalmol."},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0705","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0710","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3928\/01913913-20200824-02","article-title":"Update on the Use of Anti-VEGF Drugs in the Treatment of Retinopathy of Prematurity","volume":"57","author":"Seery","year":"2020","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0715","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/ICU.0000000000000783","article-title":"Complications of retinopathy of prematurity treatment","volume":"32","author":"Barnett","year":"2021","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0720","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1080\/02713683.2017.1319491","article-title":"Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia","volume":"42","author":"Moisseiev","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0725","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41467-017-00751-w","article-title":"Foxp3(+) Tregs are recruited to the retina to repair pathological angiogenesis","volume":"8","author":"Deliyanti","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0730","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1167\/iovs.16-20474","article-title":"Microglia Activation and Recruitment of Circulating Macrophages During Ischemic Experimental Branch Retinal Vein Occlusion","volume":"58","author":"Ebneter","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.114899_b0735","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.omtn.2019.04.029","article-title":"Exosomes from Microglia Attenuate Photoreceptor Injury and Neovascularization in an Animal Model of Retinopathy of Prematurity","volume":"16","author":"Xu","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"14","key":"10.1016\/j.addr.2023.114899_b0740","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI insight"},{"key":"10.1016\/j.addr.2023.114899_b0745","doi-asserted-by":"crossref","first-page":"3940241","DOI":"10.1155\/2017\/3940241","article-title":"Ischemic Retinopathies: Oxidative Stress and Inflammation","volume":"2017","author":"Rivera","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.addr.2023.114899_b0750","doi-asserted-by":"crossref","first-page":"7727648","DOI":"10.1155\/2021\/7727648","article-title":"Retinal Degeneration in a Murine Model of Retinal Ischemia by Unilateral Common Carotid Artery Occlusion","volume":"2021","author":"Lee","year":"2021","journal-title":"Biomed Res. Int."},{"issue":"22","key":"10.1016\/j.addr.2023.114899_b0755","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/jama.2012.85685","article-title":"Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999\u20132002 and 2005\u20132008","volume":"308","author":"Ko","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.addr.2023.114899_b0760","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/jop.2020.0083","article-title":"Protection of Retinal Function by Nucleoside Reverse Transcriptase Inhibitors Following Retinal Ischemia\/Reperfusion Injury","volume":"37","author":"Gange","year":"2021","journal-title":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0765","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00417-021-05542-0","article-title":"Role of Curcumin in Retinal Diseases-A review. Graefe's archive for clinical and experimental ophthalmology =","volume":"260","author":"Chandrasekaran","year":"2022","journal-title":"Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"10.1016\/j.addr.2023.114899_b0770","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biomaterials.2019.01.016","article-title":"Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion","volume":"197","author":"Mathew","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114899_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121484","article-title":"TNF-\u03b1 stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3\/miR-21a-5p axis","volume":"284","author":"Yu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114899_b0780","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.preteyeres.2017.10.005","article-title":"Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia","volume":"63","author":"Ohno-Matsui","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0785","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2019.1704153","article-title":"Inflammatory Choroidal Neovascularization","volume":"28","author":"Cunningham","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"6 Suppl","key":"10.1016\/j.addr.2023.114899_b0790","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/IAE.0b013e3181ad255f","article-title":"Age-related macular degeneration","volume":"29","author":"Brucker","year":"2009","journal-title":"Retina (Philadelphia, Pa)"},{"key":"10.1016\/j.addr.2023.114899_b0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-66014-7_1","article-title":"Age-Related Macular Degeneration: Epidemiology and Clinical Aspects","volume":"1256","author":"Keenan","year":"2021","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0800","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0805","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bjophthalmol-2017-311258","article-title":"Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections","volume":"102","author":"Bourne","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0810","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b0815","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","article-title":"Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)","volume":"98","author":"Schmidt-Erfurth","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.addr.2023.114899_b0820","first-page":"1857","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.addr.2023.114899_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.addr.2023.114899_b0830","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","article-title":"Molecular mechanisms of subretinal fibrosis in age-related macular degeneration","volume":"142","author":"Ishikawa","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b0835","first-page":"559","article-title":"Mesenchymal stem cells-derived exosomes ameliorate blue light stimulation in retinal pigment epithelium cells and retinal laser injury by VEGF-dependent mechanism","volume":"11","author":"He","year":"2018","journal-title":"Int J Ophthalmol"},{"issue":"39","key":"10.1016\/j.addr.2023.114899_b0840","doi-asserted-by":"crossref","first-page":"28058","DOI":"10.1074\/jbc.M113.470765","article-title":"Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization","volume":"288","author":"Hajrasouliha","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0845","doi-asserted-by":"crossref","first-page":"e12578","DOI":"10.1371\/journal.pone.0012578","article-title":"\u03b1B crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells","volume":"5","author":"Sreekumar","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b0850","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.7150\/thno.54755","article-title":"Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis","volume":"11","author":"Dong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2023.114899_b0855","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-021-00764-3","article-title":"Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells","author":"Tian","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b0860","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0161-6420(85)33837-X","article-title":"Detection of HLA class I and II antigens in rejected human corneal allografts","volume":"92","author":"Pepose","year":"1985","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0865","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/eye.2009.17","article-title":"Mechanisms of corneal allograft rejection and regional immunosuppression","volume":"23","author":"Coster","year":"2009","journal-title":"Eye (Lond.)"},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0870","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/ICO.0b013e31823f77f5","article-title":"Effect of donor and recipient factors on corneal graft rejection","volume":"31","author":"Stulting","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b0875","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.survophthal.2007.04.008","article-title":"Corneal graft rejection","volume":"52","author":"Panda","year":"2007","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0880","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9394(14)73872-3","article-title":"Local therapy of corneal allograft rejection with cyclosporine","volume":"119","author":"Zhao","year":"1995","journal-title":"Am. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0885","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0021-5155(99)00223-3","article-title":"Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty","volume":"44","author":"Inoue","year":"2000","journal-title":"Jpn. J. Ophthalmol."},{"issue":"18","key":"10.1016\/j.addr.2023.114899_b0890","doi-asserted-by":"crossref","first-page":"8446","DOI":"10.7150\/thno.31711","article-title":"Lentivirus-mediated IL-10-expressing Bone Marrow Mesenchymal Stem Cells promote corneal allograft survival via upregulating lncRNA 003946 in a rat model of corneal allograft rejection","volume":"10","author":"Lu","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0895","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13287-021-02293-x","article-title":"Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice","volume":"12","author":"Treacy","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b0900","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/ajt.12828","article-title":"Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation","volume":"14","author":"Treacy","year":"2014","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b0905","doi-asserted-by":"crossref","first-page":"86","DOI":"10.31083\/j.fbl2703086","article-title":"Mesenchymal stem cell derived exosomes-based immunological signature in a rat model of corneal allograft rejection therapy","volume":"27","author":"Jia","year":"2022","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.addr.2023.114899_b0910","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.12659\/MSM.917058","article-title":"Exosomes derived from T regulatory cells suppress CD8+ cytotoxic T lymphocyte proliferation and prolong liver allograft survival","volume":"25","author":"Chen","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0915","doi-asserted-by":"crossref","first-page":"11518","DOI":"10.1038\/s41598-017-08617-3","article-title":"Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival","volume":"7","author":"Aiello","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0920","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/TP.0000000000002442","article-title":"Local delivery of regulatory T cells promotes corneal allograft survival","volume":"103","author":"Shao","year":"2019","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0925","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"issue":"1\u20132","key":"10.1016\/j.addr.2023.114899_b0930","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.2017.0041","article-title":"Targets of neuroprotection in glaucoma","volume":"34","author":"He","year":"2018","journal-title":"J. Ocular Pharmacol. Therapeut.: Off. J. Assoc. Ocular Pharmacol. Therapeut."},{"issue":"18","key":"10.1016\/j.addr.2023.114899_b0935","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2023.114899_b0940","first-page":"1467","article-title":"Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma","volume":"8","author":"Hu","year":"2013","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b0945","first-page":"73","article-title":"Neurodegeneration and Neuroprotection in Glaucoma","volume":"89","author":"Gauthier","year":"2016","journal-title":"Yale J. Biol. Med."},{"issue":"13","key":"10.1016\/j.addr.2023.114899_b0950","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1167\/iovs.18-25310","article-title":"Mesenchymal stem cell-derived small extracellular vesicles promote neuroprotection in a genetic DBA\/2J mouse model of glaucoma","volume":"59","author":"Mead","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0955","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1167\/iovs.17-22855","article-title":"Mesenchymal stem cell-derived small extracellular vesicles promote neuroprotection in rodent models of glaucoma","volume":"59","author":"Mead","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.addr.2023.114899_b0960","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1111\/jcmm.15129","article-title":"Extracellular vesicle-mediated crosstalk between NPCE cells and TM cells result in modulation of Wnt signalling pathway and ECM remodelling","volume":"24","author":"Lerner","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b0965","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0970","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.survophthal.2019.06.007","article-title":"Phacoemulsification in review: Optimization of cataract removal in an in vitro setting","volume":"64","author":"Boulter","year":"2019","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b0975","first-page":"1250","article-title":"YAG capsulotomy rates between two types of trifocal intraocular lenses","volume":"72","author":"Ali","year":"2022","journal-title":"JPMA J. Pakistan Med. Assoc."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b0980","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jcrs.2019.05.018","article-title":"Posterior capsule opacification rate after phacoemulsification in pediatric cataract: Hydrophilic versus hydrophobic intraocular lenses","volume":"45","author":"Sen","year":"2019","journal-title":"J. Cataract. Refract. Surg."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0985","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0146-2776(84)80101-9","article-title":"Long-term follow-up of Nd:YAG laser posterior capsulotomy","volume":"10","author":"Keates","year":"1984","journal-title":"J. \u2013 Am. Intra-Ocular Implant Soc."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b0990","first-page":"45","article-title":"An Overview of Nd:YAG laser capsulotomy","volume":"3","author":"Karahan","year":"2014","journal-title":"Med. Hypothesis, Discov. Innovation Ophthalmol. J."},{"key":"10.1016\/j.addr.2023.114899_b0995","first-page":"469","article-title":"Augmented cellular uptake and homologous targeting of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety improvement","volume":"15","author":"Zhu","year":"2022","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b1000","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/bit.25307","article-title":"Co-opting biology to deliver drugs","volume":"111","author":"Yousefpour","year":"2014","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b1005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/d41573-020-00220-y","article-title":"Exosome-based candidates move into the clinic","volume":"20","author":"Cully","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b1010","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102271","article-title":"Therapeutic miRNA-enriched extracellular vesicles: current approaches and future prospects","volume":"9","author":"Munir","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b1015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI81132","article-title":"Extracellular vesicles and infectious diseases: new complexity to an old story","volume":"126","author":"Schorey","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b1020","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ibd.20860","article-title":"Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease","volume":"15","author":"Martinez-Medina","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.addr.2023.114899_b1025","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAI-0016-2019","article-title":"Interaction between intracellular bacterial pathogens and host cell mitochondria","volume":"7","author":"Spier","year":"2019","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.addr.2023.114899_b1030","article-title":"Therapeutic effect of rapamycin-loaded small extracellular vesicles derived from mesenchymal stem cells on experimental autoimmune uveitis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b1035","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.7150\/thno.69368","article-title":"Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment","volume":"12","author":"Liang","year":"2022","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.addr.2023.114899_b1040","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000875","article-title":"Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer","volume":"4","author":"McAndrews","year":"2021","journal-title":"Life Sci. Alliance"},{"issue":"5","key":"10.1016\/j.addr.2023.114899_b1045","doi-asserted-by":"crossref","first-page":"e12225","DOI":"10.1002\/jev2.12225","article-title":"Engineered Cas9 extracellular vesicles as a novel gene editing tool","volume":"11","author":"Osteikoetxea","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"3","key":"10.1016\/j.addr.2023.114899_b1050","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1039\/D0NR07622H","article-title":"Exosome-mediated delivery of gene vectors for gene therapy","volume":"13","author":"Duan","year":"2021","journal-title":"Nanoscale"},{"issue":"13\u201314","key":"10.1016\/j.addr.2023.114899_b1055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/hum.2020.328","article-title":"Intravitreal injection of an exosome-associated adeno-associated viral vector enhances retinoschisin 1 gene transduction in the mouse retina","volume":"32","author":"Wang","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.addr.2023.114899_b1060","doi-asserted-by":"crossref","first-page":"45329","DOI":"10.1038\/srep45329","article-title":"Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection","volume":"7","author":"Wassmer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114899_b1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197966","article-title":"Exosome-associated SUMOylation mutant AAV demonstrates improved ocular gene transfer efficiency in vivo","volume":"283","author":"Maurya","year":"2020","journal-title":"Virus Res."},{"issue":"7526","key":"10.1016\/j.addr.2023.114899_b1070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer's disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"issue":"51","key":"10.1016\/j.addr.2023.114899_b1075","doi-asserted-by":"crossref","first-page":"43108","DOI":"10.1074\/jbc.M112.404467","article-title":"The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space","volume":"287","author":"Perez-Gonzalez","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b1080","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.addr.2023.114899_b1085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphys.2012.00124","article-title":"Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?","volume":"3","author":"Bellingham","year":"2012","journal-title":"Front. Physiol."},{"issue":"20","key":"10.1016\/j.addr.2023.114899_b1090","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.addr.2023.114899_b1095","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1089\/dna.2017.3836","article-title":"Human endothelial progenitor cell-derived exosomes increase proliferation and angiogenesis in cardiac fibroblasts by promoting the mesenchymal-endothelial transition and reducing high mobility group box 1 protein B1 Expression","volume":"36","author":"Ke","year":"2017","journal-title":"DNA Cell Biol."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b1100","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/jbcr\/irab116","article-title":"Exosomal MicroRNA-21 promotes keloid fibroblast proliferation and collagen production by inhibiting Smad7","volume":"42","author":"Li","year":"2021","journal-title":"J. Burn. Care Res."},{"key":"10.1016\/j.addr.2023.114899_b1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121105","article-title":"Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration","volume":"608","author":"Maulvi","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.addr.2023.114899_b1110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","article-title":"Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes","volume":"18","author":"Choi","year":"2021","journal-title":"Tissue Eng. Regener. Med."},{"issue":"7","key":"10.1016\/j.addr.2023.114899_b1115","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.7150\/thno.52570","article-title":"Engineering exosomes for targeted drug delivery","volume":"11","author":"Liang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2023.114899_b1120","article-title":"Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment","volume":"13(615):eabb6981","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.addr.2023.114899_b1125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","article-title":"RNA delivery by extracellular vesicles in mammalian cells and its applications","volume":"21","author":"O'Brien","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2023.114899_b1130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/5584_2022_754","article-title":"Stem cell-derived extracellular vesicles as a potential therapeutic tool for eye diseases: from benchtop to bedside","volume":"1410","author":"Attia","year":"2023","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.addr.2023.114899_b1135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12964-022-00959-4","article-title":"A review on exosomes application in clinical trials: perspective, questions, and challenges","volume":"20","author":"Rezaie","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.addr.2023.114899_b1140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jconrel.2022.03.036","article-title":"Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy","volume":"345","author":"Rehman","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114899_b1145","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.2147\/IJN.S200036","article-title":"Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy","volume":"14","author":"Vakhshiteh","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.addr.2023.114899_b1150","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/jcmm.17689","article-title":"Exosomes for angiogenesis induction in ischemic disorders","volume":"27","author":"Moeinabadi-Bidgoli","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.addr.2023.114899_b1155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2018.00118","article-title":"Considering cell therapy product \u201cgood manufacturing practice\u201d status","volume":"5","author":"Bedford","year":"2018","journal-title":"Front. Med."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:11:27Z","timestamp":1778631087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X23002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":231,"alternative-id":["S0169409X23002144"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.114899","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in development of exosomes for ophthalmic therapeutics","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.114899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114899"}}